Association between Gastroesophageal Reflux Disease and Elastographic Parameters of Liver Steatosis and Fibrosis: Controlled Attenuation Parameter and Liver Stiffness Measurements

Table 2

Prevalence of outcomes, gastroesophageal reflux disease, Barrett’s esophagus, hiatal hernia, and insufficient cardia, among subjects divided by stages of liver fibrosis (ranges F1 to F4).

	F1 (n = 663)	F2 (n = 133)	F3 (n = 36)	F4 (n = 105)
GERD, n (%)	190 (28.66)	43 (32.33)	15 (41.67)	36 (34.29)
BE, n (%)	7 (1.06)	7 (1.50)	2 (5.56)	3 (2.86)
HH, n (%)	274 (41.33)	57 (42.86)	19 (52.78)	52 (49.52)
INSUF, n (%)	313 (47.21)	60 (45.11)	21 (58.33)	51 (48.57)
	F1-2 (n = 796)	F2-4 (n = 274)	F3-4 (n = 141)
GERD, n (%)	233 (29.27)	94 (34.31)	51 (36.17)
BE, n (%)	9 (1.13)	7 (2.55)	5 (3.55)
HH, n (%)	331 (41.58)	128 (46.72)	71 (50.35)
INSUF, n (%)	373 (46.86)	132 (48.18)	72 (51.06)
	F1-2 vs. F3-4 value	F1 vs. F2-4 value
GERD	0.123	0.102
BE	0.071	0.102
HH	0.065	0.149
INSUF	0.407	0.843

GERD: gastroesophageal reflux disease; BE: Barrett’s esophagus; HH: hiatal hernia; INSUF: insufficient cardia.